SMIM26
gene geneOn this page
Also known as LOC388789
Summary
SMIM26 (small integral membrane protein 26, HGNC:43430) is a protein-coding gene on chromosome 20p11.23, encoding Small integral membrane protein 26 (A0A096LP01). May play a role in cell viability.
Enables protein kinase binding activity and transmembrane transporter binding activity. Located in mitochondrial outer membrane.
Source: NCBI Gene 388789 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001348957
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43430 |
| Approved symbol | SMIM26 |
| Name | small integral membrane protein 26 |
| Location | 20p11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC388789 |
| Ensembl gene | ENSG00000232388 |
| Ensembl biotype | protein_coding |
| Entrez | 388789 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000411646, ENST00000435844, ENST00000608034
RefSeq mRNA: 2 — MANE Select: NM_001348957
NM_001348957, NM_001348958
CCDS: CCDS86936, CCDS86937
Canonical transcript exons
ENST00000411646 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001616030 | 18569236 | 18569560 |
| ENSE00001700959 | 18567432 | 18567596 |
Expression profiles
Bgee: expression breadth ubiquitous, 138 present calls, max score 99.20.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 67.8289 / max 725.4731, expressed in 1819 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183692 | 67.8289 | 1819 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| quadriceps femoris | UBERON:0001377 | 99.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.33 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.20 | gold quality |
| muscle of leg | UBERON:0001383 | 98.08 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.04 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.67 | gold quality |
| monocyte | CL:0000576 | 97.40 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.40 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.36 | gold quality |
| mucosa of stomach | UBERON:0001199 | 97.33 | gold quality |
| apex of heart | UBERON:0002098 | 97.31 | gold quality |
| leukocyte | CL:0000738 | 97.30 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.29 | gold quality |
| fundus of stomach | UBERON:0001160 | 97.28 | gold quality |
| left ovary | UBERON:0002119 | 97.28 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 97.28 | gold quality |
| adenohypophysis | UBERON:0002196 | 97.26 | gold quality |
| body of pancreas | UBERON:0001150 | 97.24 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.24 | gold quality |
| pituitary gland | UBERON:0000007 | 97.20 | gold quality |
| ovary | UBERON:0000992 | 97.19 | gold quality |
| heart | UBERON:0000948 | 97.17 | gold quality |
| body of stomach | UBERON:0001161 | 97.14 | gold quality |
| pancreas | UBERON:0001264 | 97.13 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 97.12 | gold quality |
| right atrium auricular region | UBERON:0006631 | 97.04 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.97 | gold quality |
| gall bladder | UBERON:0002110 | 96.96 | gold quality |
| muscle tissue | UBERON:0002385 | 96.90 | gold quality |
| popliteal artery | UBERON:0002250 | 96.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.01 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- Identification and analysis of short open reading frames (sORFs) in the initially annotated noncoding RNA LINC00493 from human cells. (PMID:33386847)
- Investigation of LINC00493/SMIM26 Gene Suggests Its Dual Functioning at mRNA and Protein Level. (PMID:34445188)
- LINC00493-encoded microprotein SMIM26 exerts anti-metastatic activity in renal cell carcinoma. (PMID:37009826)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Smim26 | ENSMUSG00000074754 |
| rattus_norvegicus | Smim26 | ENSRNOG00000036971 |
Protein
Protein identifiers
Small integral membrane protein 26 — A0A096LP01 (reviewed: A0A096LP01)
All UniProt accessions (2): A0A096LP01, A0A096LPB8
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in cell viability.
Subunit / interactions. Interacts with AGK and SLC25A11.
Subcellular location. Mitochondrion outer membrane.
Tissue specificity. Detected in kidney (at protein level).
Miscellaneous. Suppresses clear cell renal cell carcinoma growth and metastatis. In renal cancer cell lines, interaction with SLC25A11 maintains mitochondrial glutathione and enhances mitochondrial metabolism. In renal cancer cell lines, interaction with AGK promotes AGK mitochondrial localization and inactivates AGK-mediated AKT phosphorylation, leading to inhibition of AKT signaling and repression of metastasis.
Similarity. Belongs to the SMIM26 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A0A096LP01-1 | 1 | yes |
| A0A096LP01-2 | 2 |
RefSeq proteins (2): NP_001335886, NP_001335887 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038831 | SMIM26 | Family |
UniProt features (3 total): chain 1, transmembrane region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A096LP01-F1 | 72.61 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 32 (showing top):
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, GOCC_MITOCHONDRIAL_ENVELOPE, chr20p11, GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING, GOMF_KINASE_BINDING, GOCC_ORGANELLE_ENVELOPE, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, KAT5_TARGET_GENES, SETD7_TARGET_GENES, UBN1_TARGET_GENES, ZNF2_TARGET_GENES, ZNF618_TARGET_GENES, ZNF711_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (3): protein kinase binding (GO:0019901), transmembrane transporter binding (GO:0044325), protein binding (GO:0005515)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial outer membrane (GO:0005741), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| kinase binding | 1 |
| protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
480 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMIM26 | OXLD1 | Q5BKU9 | 451 |
| SMIM26 | ANTKMT | Q9BQD7 | 416 |
| SMIM26 | TMEM242 | Q9NWH2 | 411 |
| SMIM26 | TEX261 | Q6UWH6 | 401 |
| SMIM26 | PIGBOS1 | A0A0B4J2F0 | 399 |
| SMIM26 | LYRM9 | A8MSI8 | 383 |
| SMIM26 | SNAPC5 | O75971 | 370 |
| SMIM26 | ZNF343 | Q6P1L6 | 368 |
| SMIM26 | YARS1 | P54577 | 351 |
| SMIM26 | FAM110A | Q9BQ89 | 348 |
| SMIM26 | LONRF3 | Q496Y0 | 331 |
| SMIM26 | MIGA2 | Q7L4E1 | 326 |
| SMIM26 | AP5S1 | Q9NUS5 | 310 |
| SMIM26 | NRSN2 | Q9GZP1 | 306 |
| SMIM26 | ZNF133 | P52736 | 300 |
IntAct
26 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMIM26 | AGK | psi-mi:“MI:0915”(physical association) | 0.650 |
| SMIM26 | AGK | psi-mi:“MI:0403”(colocalization) | 0.650 |
| AGK | SMIM26 | psi-mi:“MI:0403”(colocalization) | 0.650 |
| AGK | SMIM26 | psi-mi:“MI:0914”(association) | 0.650 |
| SMIM26 | AGK | psi-mi:“MI:0914”(association) | 0.650 |
| SMIM26 | SLC25A11 | psi-mi:“MI:0915”(physical association) | 0.630 |
| SMIM26 | SLC25A11 | psi-mi:“MI:0403”(colocalization) | 0.630 |
| SLC25A11 | SMIM26 | psi-mi:“MI:0915”(physical association) | 0.630 |
| SMIM26 | SLC25A11 | psi-mi:“MI:0914”(association) | 0.630 |
| SMIM26 | CNOT1 | psi-mi:“MI:0914”(association) | 0.350 |
| SMIM26 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| SMIM26 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A096LP01, A3LP48, A3LQD9, A5DLM7, A6SAY2, A6ZLK2, A7EJE5, A7TMN2, B3LMP9, B9WD58, C4YPM0, C5DRK2, C5E381, C7GMW8, D3UF10, G2TRJ9, O22912, O74383, O95167, P0DN34, P19173, P20609, P20610, P26310, P38341, P48306, Q02365, Q02371, Q0MQ94, Q0MQ95, Q0MQ96, Q2KP58, Q2V2Q3, Q42841, Q59LP6, Q59QC6, Q6BL60, Q6C5S0, Q6CHT7, Q752G2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
150 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:18567593:TCAG:T | donor_loss | 1.0000 |
| 20:18567594:CAG:C | donor_loss | 1.0000 |
| 20:18567595:AGG:A | donor_loss | 1.0000 |
| 20:18567596:GGTAG:G | donor_loss | 1.0000 |
| 20:18567597:GTA:G | donor_loss | 1.0000 |
| 20:18567598:T:A | donor_loss | 1.0000 |
| 20:18569223:A:AG | acceptor_gain | 1.0000 |
| 20:18569223:AAT:A | acceptor_gain | 1.0000 |
| 20:18569223:AATG:A | acceptor_gain | 1.0000 |
| 20:18569224:A:G | acceptor_gain | 1.0000 |
| 20:18569224:AT:A | acceptor_gain | 1.0000 |
| 20:18569224:ATGGT:A | acceptor_gain | 1.0000 |
| 20:18569225:T:A | acceptor_gain | 1.0000 |
| 20:18569225:T:G | acceptor_gain | 1.0000 |
| 20:18569235:GTA:G | acceptor_gain | 1.0000 |
| 20:18569224:ATG:A | acceptor_gain | 0.9900 |
| 20:18569226:G:A | acceptor_gain | 0.9900 |
| 20:18569228:T:TA | acceptor_gain | 0.9900 |
| 20:18569235:GT:G | acceptor_gain | 0.9900 |
| 20:18569232:A:AG | acceptor_gain | 0.9800 |
| 20:18569233:A:G | acceptor_gain | 0.9800 |
| 20:18569234:A:AG | acceptor_gain | 0.9800 |
| 20:18569235:G:GG | acceptor_gain | 0.9800 |
| 20:18569237:A:AG | acceptor_gain | 0.9800 |
| 20:18569238:G:GA | acceptor_gain | 0.9800 |
| 20:18569235:GTAGA:G | acceptor_gain | 0.9700 |
| 20:18567523:G:GA | donor_gain | 0.9600 |
| 20:18567546:C:A | donor_gain | 0.9500 |
| 20:18567597:G:GG | donor_gain | 0.9500 |
| 20:18569231:TAAAG:T | acceptor_loss | 0.9500 |
AlphaMissense
598 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:18567542:T:A | W22R | 0.951 |
| 20:18567542:T:C | W22R | 0.951 |
| 20:18567555:G:A | G26D | 0.942 |
| 20:18567525:T:A | V16D | 0.933 |
| 20:18567537:G:A | G20D | 0.920 |
| 20:18567554:G:C | G26R | 0.914 |
| 20:18567536:G:C | G20R | 0.898 |
| 20:18567531:G:A | G18E | 0.882 |
| 20:18567527:T:G | Y17D | 0.881 |
| 20:18567530:G:A | G18R | 0.867 |
| 20:18567530:G:C | G18R | 0.867 |
| 20:18569298:T:C | F61L | 0.856 |
| 20:18569300:T:A | F61L | 0.856 |
| 20:18569300:T:G | F61L | 0.856 |
| 20:18567534:T:A | I19N | 0.851 |
| 20:18569334:T:C | F73L | 0.851 |
| 20:18569336:T:A | F73L | 0.851 |
| 20:18569336:T:G | F73L | 0.851 |
| 20:18567549:T:A | V24E | 0.840 |
| 20:18569356:T:C | I80T | 0.839 |
| 20:18567494:T:C | F6L | 0.808 |
| 20:18567496:C:A | F6L | 0.808 |
| 20:18567496:C:G | F6L | 0.808 |
| 20:18569376:T:A | W87R | 0.800 |
| 20:18569376:T:C | W87R | 0.800 |
| 20:18567522:T:A | V15E | 0.795 |
| 20:18567545:T:C | S23P | 0.793 |
| 20:18567503:T:A | W9R | 0.791 |
| 20:18567503:T:C | W9R | 0.791 |
| 20:18569378:G:C | W87C | 0.790 |
dbSNP variants (sampled 300 via entrez): RS1000467834 (20:18567232 T>A), RS1001051530 (20:18568471 C>T), RS1001419066 (20:18568815 C>G,T), RS1001679556 (20:18565942 A>G), RS1001731867 (20:18565636 C>T), RS1003180458 (20:18566261 T>G), RS1003859963 (20:18567647 G>A), RS1004893706 (20:18568865 C>G), RS1005234333 (20:18566772 C>T), RS1005267976 (20:18569116 T>A), RS1005945284 (20:18566328 A>C,G,T), RS1006646254 (20:18565542 C>T), RS1006650677 (20:18569656 G>A,C), RS1007412627 (20:18565874 G>A), RS1008051770 (20:18568132 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| Temozolomide | increases expression | 1 |
| Testosterone | decreases expression | 1 |
| Zinc | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E2KD | HAP1 SMIM26 (-) 1 | Cancer cell line | Male |
| CVCL_E2KE | HAP1 SMIM26 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.